A New Product of Bilirubin Degradation by H2O2 and Its Formation in Activated Neutrophils and in an Inflammatory Mouse Model
Open Access
- 4 September 2022
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 12 (9) , 1237
Abstract
Bilirubin (BR) is a tetrapyrrolic compound stemming from heme catabolism with diverse physiological functions. It can be oxidized by H2O2 to form several degradation products, some of which have been detected in vivo and may contribute to the pathogenesis of certain diseases. However, the oxidative degradation of BR is complex and the conditions that BR degradation occurs pathophysiologically remain obscure. Neutrophils are known to generate large amounts of reactive oxygen species, including H2O2, upon activation and they are mobilized to inflammatory sites; therefore, we hypothesized that activated neutrophils could cause BR degradation, which could occur at inflammatory sites. In the present study, we investigated BR degradation by H2O2 and identified hematinic acid (BHP1) and a new product BHP2, whose structure was characterized as 2,5-diformyl-4-methyl-1H-pyrrole-3-propanoic acid. An LC-MS/MS method for the quantitation of the two compounds was then established. Using the LC-MS/MS method, we observed the concentration-dependent formation of BHP1 and BHP2 in mouse neutrophils incubated with 10 and 30 μM of BR with the yields being 16 ± 3.2 and 31 ± 5.9 pmol/106 cells for BHP1, and 25 ± 4.4 and 71 ± 26 pmol/106 cells for BHP2, respectively. After adding phorbol 12-myristate 13-acetate, a neutrophil agonist, to 30 μM of BR-treated cells, the BHP1 yield increased to 43 ± 6.6 pmol/106 cells, whereas the BHP2 one decreased to 47 ± 9.2 pmol/106 cells. The two products were also detected in hemorrhagic skins of mice with dermal inflammation and hemorrhage at levels of 4.5 ± 1.9 and 0.18 ± 0.10 nmol/g tissue, respectively, which were significantly higher than those in the non-hemorrhagic skins. BHP2 was neurotoxic starting at 0.10 μM but BHP1 was not, as assessed using Caenorhabditis elegans as the animal model. Neutrophil-mediated BR degradation may be a universally pathophysiological process in inflammation and can be particularly important under pathological conditions concerning hemorrhage.Keywords
Funding Information
- National Natural Science Foundation of China (21976120, 81761138045, 41675123)
This publication has 49 references indexed in Scilit:
- Detection and imaging of the free radical DNA in cells--Site-specific radical formation induced by Fenton chemistry and its repair in cellular DNA as seen by electron spin resonance, immuno-spin trapping and confocal microscopyNucleic Acids Research, 2012
- Unconjugated Bilirubin Contributes to Early Inflammation and Edema after Intracerebral HemorrhageJournal of Cerebral Blood Flow & Metabolism, 2010
- Bilirubin Oxidation End Products Directly Alter K+ Channels Important in the Regulation of Vascular ToneJournal of Cerebral Blood Flow & Metabolism, 2010
- Heme Degradation and Vascular InjuryAntioxidants & Redox Signaling, 2010
- A non‐redundant role for MKP5 in limiting ROS production and preventing LPS‐induced vascular injuryThe EMBO Journal, 2009
- Mos1Mutagenesis Reveals a Diversity of Mechanisms Affecting Response ofCaenorhabditis elegansto the Bacterial PathogenMicrobacterium nematophilumGenetics, 2007
- Bilirubin degradation by uncoupled cytochrome P450. Comparison with a chemical oxidation system and characterization of the products by high‐performance liquid chromatography/electrospray ionization mass spectrometryRapid Communications in Mass Spectrometry, 2006
- Increase of metabolic activity and disruption of normal contractile protein distribution by bilirubin oxidation products in vascular smooth-muscle cellsJournal of Neurosurgery, 2004
- Facile Synthesis of Hematinic AcidSynthetic Communications, 1998
- Assessment of the active-site requirements of 5-aminolevulinic acid dehydratase: evaluation of substrate and product analogs as competitive inhibitorsThe Journal of Organic Chemistry, 1992